Stock 3KY HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Hansoh Pharmaceutical Group Company Limited Börse Stuttgart

Equities

3KY

KYG549581067

Market Closed - Börse Stuttgart
Other stock markets
 04:31:18 2024-07-12 am EDT 		5-day change 1st Jan Change
1.95 EUR +4.28% Intraday chart for Hansoh Pharmaceutical Group Company Limited +1.08% +9.36%
Jun. 14 Hansoh Pharmaceutical Slashes Conversion Price of Convertible Bonds MT
Apr. 30 Hansoh Pharmaceutical’s 2023 Profit Up 27% MT

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hansoh Pharmaceutical Slashes Conversion Price of Convertible Bonds
MT
Hansoh Pharmaceutical’s 2023 Profit Up 27%
MT
Hansoh Pharmaceutical Secures Chinese Nod for Trial of Anti-Cancer Drug
MT
Hansoh Pharmaceutical Group Company Limited, Jiangsu Hansoh Pharmaceutical Group Company Limited and Shanghai Hansoh Biomedical Technology Company Limited Receives Grant of A Clinical Trial Notice Issued by the National Medical Products Administration of the People's Republic of China to Be Used for the Treatment of Advanced Non-Small Cell Lung Cancer
CI
Hansoh Pharmaceutical Group Company Limited Recommends Final Dividend, Payable on July 17, 2024
CI
Hansoh Pharmaceutical Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules
MT
Hansoh Pharmaceutical Buys Back 3 Million Shares
MT
Hansoh Secures Chinese Nod For Clinical Trial Of Anti-Diabetes Drug
MT
Hansoh Pharmaceutical Units Gets Clinical Trial Notice in China for Schizophrenia Treatment
MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of HS-10509 Tablets
CI
Hansoh Pharmaceutical’s Trustee Buys Back Shares
MT
GSK plc Enters Exclusive License Agreement with Hansoh for HS-20093
CI
GSK looks for deals in China as rebuilds relationship
AN
Hansoh Pharma's Three Drugs Added to China’s National Reimbursement Drug List
MT
China OKs Clinical Trial for Hansoh Pharmaceutical Units' Hypertrophic Cardiomyopathy Treatment
MT
Shanghai Hansoh Biomedical Technology Company Limited and Jiangsu Hansoh Pharmaceutical Group Company Limited Receives Clinical Trial Notice
CI
China Grants Drug Registration Approval for Hansoh Pharma Unit's Skin Infection Treatment
MT
Hansoh Pharmaceutical Gets Nod to Test HS-20106 Injections
MT
Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of Hs-20106 Injections
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 3692 Stock
  4. 3KY Stock
  5. News Hansoh Pharmaceutical Group Company Limited
  6. Highlights